Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

Back

ESC Professional Premium Access

Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

Session: Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Topic: Oral Anticoagulation

Speaker: Doctor R. Aggarwal (Boston, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

4 more presentations in this session

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Speaker: Professor G. Lip (Liverpool, GB)

Access

Slides

Video

Repeated measurement of the novel atrial biomarker BMP10 improves risk stratification in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial

Speaker: Doctor K. Gkarmiris (Uppsala, SE)

Differences in causality between exposures and stroke subtypes: a mendelian randomisation approach

Speaker: Associate Professor G. Klappacher (Vienna, AT)

Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

Speaker: Doctor M. Anjum (Baerum, NO)

Access the full session

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Speakers: Doctor R. Aggarwal, Professor G. Lip, Doctor K. Gkarmiris, Associate Professor G. Klappacher, Doctor M. Anjum

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources